Understanding how acute pancreatitis leads to diabetes in African Americans and Hispanics
Mechanisms of diabetes from acute pancreatitis in African Americans and Hispanics
This study is looking at how having acute pancreatitis might lead to diabetes, especially in African American and Hispanic communities, and it wants to understand the role of gut bacteria in this process.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10894893 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which acute pancreatitis (AP) can lead to the development of diabetes, particularly focusing on African American and Hispanic populations. It aims to explore the relationship between AP and different types of diabetes, including type 1 and type 2 diabetes, while also examining the role of gut microbiota in this process. By leveraging a diverse cohort of patients, the study seeks to identify risk factors and biological mechanisms that contribute to diabetes following AP. The research employs a multidisciplinary approach, integrating expertise in clinical pancreatology, diabetes, and health disparities.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American and Hispanic individuals who have experienced acute pancreatitis.
Not a fit: Patients who do not have a history of acute pancreatitis or are not from the targeted racial groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of diabetes in populations disproportionately affected by this condition.
How similar studies have performed: While the relationship between acute pancreatitis and diabetes has been explored, this specific focus on African American and Hispanic populations and the role of gut microbiota is relatively novel.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Yazici, Cemal — University of Illinois at Chicago
- Study coordinator: Yazici, Cemal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.